Advanced intelligent Clear-IQ Engine (AiCE)
Deep Learning reconstruction technology for CT, MRI, and PET-CT imaging
Software · EmbeddedCompany source
Company profile
About Canon Medical
Canon Medical Systems is a leading global manufacturer of advanced medical imaging equipment and healthcare IT solutions. The company provides a comprehensive portfolio of diagnostic imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray, angiography systems, and molecular imaging (PET-CT). Canon Medical has introduced Altivity, its AI innovation platform that integrates artificial intelligence across the entire care pathway to enhance clinical confidence, optimize workflows, and deliver personalized patient care. The company's imaging systems incorporate advanced AI technologies such as the Advanced intelligent Clear-IQ Engine (AiCE) for deep learning-based image reconstruction and the Precise IQ Engine (PIQE) for enhanced image quality. Canon Medical serves diverse healthcare segments including interventional cardiology, radiology, oncology, neurology, and women's health. The company emphasizes patient-centered care through innovations like quiet MRI technology, dose reduction in X-ray imaging, and flexible system configurations. Canon Medical's solutions are designed for health systems, hospitals, imaging centers, and specialized clinical practices globally. As part of Canon Inc., the company combines imaging expertise with manufacturing capabilities to deliver reliable, high-quality medical equipment. Canon Medical is committed to advancing healthcare through continuous innovation in AI-assisted imaging, efficient workflows, and collaborative care delivery.
Company description Canon Medical official website
Mission. Made for Life.
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Canon Medical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiology
- Lung Cancer
- Musculoskeletal conditions
- Neurological conditions
- Oncology
- Prostate
- Stroke
- Vascular diseases
- Women's health conditions
Who it serves
- Cardiology Departments
- Health Systems
- Hospitals
- Imaging Centers
- Interventional Labs
- Radiology Departments
Deployment & integration
Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: DICOM, Healthcare IT platforms, IHE, Vitrea Advanced Visualization.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
Launch of Altivity AI innovation platform; Introduction of Photon Counting CT; Development of αEvolve Imaging fluoroscopy with deep learning-based noise reduction
Partnerships
Recorded partners
- Canon Inc. (parent company for manufacturing)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Alphenix
Flexible angiography system with AI-enhanced fluoroscopy
Device · On PremiseCompany source
Altivity
AI-assisted imaging platform for enhanced clinical confidence and efficient workflows
Platform · EmbeddedCompany source
Aplio i-series
Premium ultrasound system with Prism Edition AI features
Device · On PremiseCompany source
Aquilion ONE
Area Detector CT with AI-enhanced imaging capabilities
Device · On PremiseCompany source
Aquilion Precision
Ultra-High Resolution CT scanner with AI reconstruction
Device · On PremiseCompany source
Cartesion Prime
Digital PET-CT with AI-powered Deep Learning reconstruction
Device · On PremiseCompany source
Precise IQ Engine (PIQE)
AI-powered image quality enhancement for CT and MRI systems
Software · EmbeddedCompany source
Vantage Centurian
3T MRI system with AI reconstruction and quiet technology
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Subtraction iodine maps combined with deep learning reconstruction for improved evaluation of bony invasion in temporal bone lesions.European radiology · Oct 9, 2026
Diffusion Basis Spectrum Imaging (DBSI): A Multicompartment Diffusion Model Linking Regional Microstructural Heterogeneity With Proliferation and Survival in High-Grade Gliomas.Journal of magnetic resonance imaging : JMRI · Oct 2, 2026
Quantification of plaque and detection of high-risk plaque characteristics based on coronary computed tomography angiography: comparison between superresolution deep learning reconstruction and hybrid iterative reconstruction.Quantitative imaging in medicine and surgery · Oct 1, 2026
Evaluation of registration accuracy using short-arc cone-beam computed tomography for image-guided radiotherapy in breast cancer.Journal of applied clinical medical physics · Oct 1, 2026
A rapid automated segmentation method for total kidney volume measurement on unenhanced computed tomography in autosomal dominant polycystic kidney disease.Abdominal radiology (New York) · Sep 26, 2026
T2 mapping of the heart: correlation with measures of cardiopulmonary MRI in COVID-19 convalescents.Magnetic resonance imaging · Sep 25, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) PlanningK260324 · 510k · May 22, 2026
Aquilion ONE (TSX-308A/TSX-306A) V2.0K253596 · 510k · May 20, 2026
Vantage Fortian/Orian 1.5T, MRT-1550, V10.0 with AiCE Reconstruction Processing Unit for MRK253625 · 510k · Mar 27, 2026
Aquilion ServeSP (TSX-307B) V2.0K260078 · 510k · Mar 13, 2026
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging (FOV Extension)K253584 · 510k · Mar 10, 2026
Cartesion Prime (PCD-1000A/3) V10.21K251370 · 510k · Dec 1, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Enhanced clinical confidence through high-quality AI-enhanced images
Real-time decision support at point of care
Optimized resource deployment and workflow efficiency
AI-driven streamlined workflows
Reduced scan times and improved signal-to-noise ratios
AiCE deep learning reconstruction in PET-CT
Reduced patient X-ray exposure while optimizing image quality
Dose management features
Improved patient comfort
Quietest MRI noise reduction technology and wide bore design
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Canon Medical
Recent articles published on Canon Medical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.